GlaxoSmithKline Consumer Healthcare has received an approval from the Competition Commission of India (CCI) for its merger deal with Hindustan Unilever (HUL).
The scheme remains subject to the receipt of other necessary statutory and regulatory approvals under applicable laws, including by the NSE, SSE, SEBI, NCLT and the respective shareholders and creditors of HUL and the company.
Glaxosmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks.
| Company Name | CMP |
|---|---|
| Varun Beverages | 509.05 |
| Nestle | 1482.20 |
| Britannia Inds | 5519.20 |
| LT Foods | 430.65 |
| Hatsun Agro Product | 988.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: